Background and objective: The prognostic nutritional index (PNI) is based on the serum albumin level and lymphocyte count, and is a useful predictor of survival in various cancers. However, the utility of PNI in lung cancer has not been examined. The aim of this study is to assess PNI as a prognostic factor in elderly patients after surgery for primary lung cancer. Methods: A retrospective review was performed in 131 elderly patients (≥75 years old) with lung cancer who underwent curative operations at our hospital from July 2008 to December 2014. Survival was calculated by the Kaplan-Meier method. The effects of PNI and clinicopathological factors on survival were evaluated in univariate and multivariate Cox regression analyses. Results: The 5-year cancer-specific survival (CSS) rates of patients with PNI ≥ 45 and <45 were 76.2% and 47.8%, respectively (P = 0.0166), and the 5-year overall survival (OS) rates were 61.9% and 39.8%, respectively (P = 0.0275). Among patients who died within 5 years, mortality due to other diseases was 31%. Univariate analysis identified gender (P = 0.003), serum carcinoembryonic antigen (CEA) (P = 0.009), PNI (P = 0.027), c-stage (P = 0.005), histological type (P = 0.001) and p-stage (P < 0.001) as prognostic factors. In multivariate analysis, CEA (HR 2.487, P = 0.0169), PNI (HR 2.737, P = 0.0289) and p-stage (HR 3.294, P = 0.007) were independent prognostic factors in elderly patients after curative surgery for lung cancer. Conclusions: CEA, PNI and p-stage are independent prognostic factors in elderly patients after surgery for primary lung cancer. Therefore, determination of preoperative PNI may be useful for treatment planning in elderly patients with lung cancer.
Introduction
Lung cancer surgeries in elderly patients have increased in number due to aging of society. In Japan, the 5-year survival rates for patients aged <50, ≥50 to <70 and ≥70 years are 69.9%, 66.0% and 54.9%, respectively (1) , and mortality from other diseases is higher than that from cancer after surgery. Surgical mortality and morbidities in elderly people are expected to be higher than in younger patients, and the life expectancy of elderly people with lung cancer may be limited by death from natural causes (2) . Elderly patients usually have various comorbidities, and Charlson comorbidity index (CCI) ≥3 is high risk group. Preoperative examinations have generally focused on respiratory function, but in elderly patients the PNI may be a more important indicator of general condition, since elderly patients for lung cancer with poor nutrition have a poor prognosis. The PNI in elderly patients is a useful guide for surgical management, anticipation of postoperative complications, and estimation of the postoperative pathological tumor stage (3) . Preoperative nutritional and immunological status are also associated with long-term outcomes in patients with various malignant tumors (4) (5) (6) (7) (8) (9) .
Little is known about the clinical value of the PNI after surgery for lung cancer. Some recent reports have stated that PNI is an independent predictor of recurrence or survival in patients with lung cancer (10) (11) (12) (13) (14) (15) (16) (17) . To our knowledge, there are no reports on the influence of PNI in elderly patients with lung cancer. Therefore, we hypothesized that the preoperative PNI is correlated with prognosis after surgery in elderly patients with lung cancer. The aim of this study was to evaluate PNI as a convenient predictive factor in this patient population.
Methods

Study design and case selection
Between July 2008 to December 2014, 419 consecutive patients with primary lung cancer underwent complete surgical resection at the Department of General Thoracic Surgery, Nihonkai General Hospital. The adjuvant chemotherapy or radiotherapy was routine program for NSCLC according to the National Comprehensive Cancer Network (NCCN). Among them, 131 elderly patients were retrospectively evaluated in this study, based on inclusion criteria of age ≥75 years old, no preoperative treatment, sufficient preoperative laboratory data from blood samples, complete clinicopathological information, and clinical and pathological staging based on the seventh edition of the Union for International Cancer Control TNM classification (18) . Patients with hematological disorders or autoimmune disease were excluded. The lung cancer database used in this study has general approval for use from the Ethics Committee of Nihonkai General Hospital. Data were handled without any possibility of identifying individual patients, and therefore written consent was not required.
All preoperative medical records were reviewed retrospectively. Immune and nutritional statuses were obtained using data from preoperative blood tests 7-14 days before operation. PNI was calculated as 10 × serum albumin (g/dl) + 0.005 × peripheral lymphocyte count (per mm 3 ) (19) The cutoff value used in the present study was different from those in previous reports. A cutoff value of 45 is commonly used because resection and anastomosis of the gastrointestinal tract can be safely performed in cases with PNI > 45 (19) . Therefore, according to first report, patients were classified into high PNI (≥45, n = 111, 84.7%) and low PNI (<45, n = 20, 15.3%) groups. A total of 131 patients were followed up until death from any cause or the last day of follow-up. Median follow-up time was 46.8 months. Overall survival (OS) was calculated from the date of definitive resection to the date of death from any cause or last follow-up.
Statistical analysis
Statistical analyses were performed using JMP ver.11 (SAS Institute Inc., Cary, NC, USA) and R software. A Student t test was used to analyze continuous variables, and a χ 2 test was used to analyze categorical variables. Comparisons of parameters in the high and low PNI groups were performed by Fisher exact test. OS and cancerspecific survival (CSS) curves were estimated using the KaplanMeier method, and differences in survival were assessed by log rank test. Univariate analysis for OS was also performed by log rank test. Multivariate analysis with a Cox proportional hazards model was used to determine significant factors for OS. Significance was set at P < 0.05 in all analyses.
Results
Baseline characteristics
A total of 131 patients were eligible for the study. The background of these patients is shown in 
Association of preoperative PNI with clinicopathological characteristics
Relationships between PNI and clinicopathological characteristics are shown in Table 1 . There were significant differences in gender (P = 0.003), CEA (P = 0.009), c-stage (P = 0.005), histological type (P = 0.001), and p-stage (P < 0.001), but no other factors, including CCI, approach, procedures, lymph node dissection, postoperative complications between the low PNI (<45) and high PNI (≥45) groups.
Association of preoperative PNI with CSS and OS
The 5-year CSS rates of patients in the high PNI (≥45) and low PNI (<45) groups were 76.2% and 47.8%, respectively (P = 0.0166) (Fig. 1) , and the 5-year OS rates were 61.9% and 39.8%, respectively (P = 0.0275) (Fig. 2) . Mortality due to other diseases was higher than that due to cancer after surgery.
Prognostic significance in elderly patients
Results of univariate and multivariate analyses of OS are shown in Table 2 . Univariate analysis showed that gender, CEA, PNI, histological type, c-stage and p-stage were significantly associated with poor survival, but CCI (P = 0.107), approach (P = 0.988), procedure (P = 0.318), lymph node dissection (P = 0.282), and postoperative complications (P = 0.153) did not show this association. Multivariate analysis showed that CEA (HR: 2.487; 95% Cl: 1.175-5.517; P = 0.0169), PNI (HR: 2.737; 95% Cl: 1.118-6.088;
Discussion
Lung cancer remains the leading cause of cancer-related mortality, despite early detection and therapy. The results of this study suggest that low PNI predicts a poor prognosis in elderly patients with lung cancer after complete resection. At the time of lung cancer diagnosis, >80% of octogenarians have at least one associated disease and >50% have two or more adverse prognostic comorbidities (20) . Increasing age is associated with higher rates of comorbid diseases and increased malnutrition-related mortality (21) . Malnutrition is a risk for morbidity and mortality in critical-care and surgical patients, and more surgical comorbidities are seen in elderly patients than in younger patients (22, 23) . For example, elderly patients with gastric cancer have high incidences of comorbidities and postoperative complications because of a general reduction in functional reserve capacity (24) . However, surgeons have to make a decision of whether to offer resection to elderly patients with lung cancer because elderly patients with early stage lung cancer have a chance of cure, even if the operative risk is high. Surgical treatment should not be denied due to age alone, and preoperative respiratory function and general condition are more important in this decision. Smoking habit and chronic obstructive pulmonary disease (COPD) and aging is frequently associated with malnutrition and inflammation. However, in a recent report, PNI score was not associated with smoking and the prevalence of COPD (25) . We dare to use Charlson comorbidity index (CCI) as general medical status for elderly patients. Guerra et al. suggested that non-small cell lung cancer (NSCLC) can be resected safely with acceptable long-term survival in selected patients aged ≥80 years old (2) .
PNI is a useful predictor for prognosis of malignant tumors, including esophageal, gastric, colorectal, pancreatic cancers, malignant pleural mesothelioma and hepatocellular carcinoma (4-9). Patients with low PNI are likely to have an advanced tumor, and Watanabe et al. found that low PNI was a poor prognostic factor in patients aged >75 years who received gastrectomy due to gastric cancer (26) . PNI > 45 has been associated with safe gastrointestinal surgery (19) , and recent studies have shown the prognostic value of PNI in NSCLC (3, (10) (11) (12) (13) (14) (15) (16) 27 ) and small cell lung cancer (SCLC) (17, 28) . Buzby et al. initially reported PNI as a prognostic indicator after digestive surgery (29) , while Onodera et al. proposed PNI as a predictor of postoperative complications in gastrointestinal surgery (19) . PNI has generally been used as a simple and accessible index to assess nutritional status in cancer patients. In this study, we found no significant correlation between PNI and postoperative complications, but the optimal PNI cutoff value is unclear. This cutoff has differed among studies because of differences in statistical analysis and biological and clinicopathological characteristics (14) . A metaanalysis suggested a clinical cutoff of 45.5 in gastric cancer (30) and Bayesian information criterion suggested a 41-45-58 four-stage division as optimal PNI cut-offs for classifying prognosis in colorectal cancer (31) . In NSCLS, cutoff values of 47.9-52 have been suggested (10) (11) (12) (13) (14) (15) (16) .
PNI depends on albumin levels and total lymphocyte counts. Patients with low PNI have been shown to have prolonged postoperative hospital stays compared with those with high PNI (14) , but whether low PNI is a cause or a consequence of tumor progression is unclear (32) . There are several reasons why low PNI is associated with worse OS and disease-free interval. PNI reflects Figure 1 . Cancer-specific survival curves based on preoperative prognostic nutritional index (PNI). Survival of patients with a low PNI (<45) was significantly poorer than that of patients with a high PNI (≥45). Figure 2 . Overall survival curves based on preoperative prognostic nutritional index (PNI). Survival of patients with a low PNI (<45) was significantly poorer than that of patients with a high PNI (≥45). Mortality due to other diseases was higher than that due to cancer after surgery.
immunological and nutritional status, and may be a good immunenutritional marker (10) . Hypoalbuminemia is regarded as an index of malnutrition and cachexia, while the total lymphocyte count is an index of systemic inflammation (33) . Malnutrition and an impaired immune system appear to work together to promote tumor development, and malnutrition is associated with an increased risk of complications and decreased tolerance to anticancer treatments (14, 34, 35) . T-and B-lymphocytes and neutrophils have been suggested to play prominent roles in tumor inflammation and immunology (16, 36) , and the total neutrophil and lymphocyte count is a strong predictor of survival (4, 37) .
Indexes of nutritional condition and systematic inflammation, such as the PNI, the Controlling Nutritional Status Index (CONUT) (38) , Glasgow prognostic score (GPS) (3), and neutrophil/lymphocyte ratio (NLR) (12, 16) , may be useful for identifying cases at high risk for early recurrence or those that could benefit from adjuvant therapy (10, 39) . Moreover, both NLR and PNI might predict response to Nivolumab and might be useful biomarker (40) . Multimodality therapies may prolong survival after surgery. We consider these marker are inexpensive and widely useful biomarker. PNI is a simple predictor index, but whether PNI is a most useful index is controversial. Tong et al. reported Systemic immuneinflammation index defined platelet counts × NLR is superior to NLR, PLR and PNI in terms of prognostic ability (41) . Additional validation is the subject of future study. Elderly patients with high PNI are likely to have a good general condition and this information may be useful in treatment planning. Pulmonary resection as curative surgery may be most appropriate for elderly patients with high PNI, while perioperative care is particularly important for elderly patients with low PNI. Activities of daily living and quality of life after surgery are important concerns for elderly patients and their family in making a choice of surgery. We cannot conclude that low PNI may be a cause or a result of tumor malignancy. However, low PNI even in elderly patients might need further therapy such as induction therapy or adjuvant therapy and more attentive follow-up after surgery.
There are several limitations in the study. First, the retrospective study design and small number of patients from a single center may produce some selection bias. Second, the presence of inflammation was not evaluated, and an inflammatory condition may affect serum albumin levels and lymphocyte counts. Third, we should use ROC curve analysis to get the optimal cutoff value of our data in elderly lung cancer patients and evaluate the prognostic factor by the cutoff value.
However, to our knowledge, this is the first study to evaluate the role of PNI as a prognostic factor in elderly lung cancer patients. Within these limitations, we conclude that a low PNI in elderly patients with lung cancer is an independent predictor of a poor prognosis after surgery. PNI is an inexpensive and simple marker, and further prospective studies are needed to evaluate cutoff values for preoperative PNI as a prognostic indicator for elderly patients after surgery for lung cancer.
Conclusions
Preoperative PNI might be useful biomarker in treatment planning and an independent predictor of survival in elderly patients after surgery for lung cancer. Preoperative low PNI even in elderly patients might need further therapy such as induction therapy or adjuvant therapy and more attentive follow-up after surgery.
